PSNL
Companies
NASDAQ
Personalis Inc.
Health Care
$6.37
+$0.59 (+10.12%)
Price Chart
Overview
About PSNL
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Market Cap
$70.1M
Volume
5.8M
Avg. Volume
4.7M
P/E Ratio
-4.380531
Dividend Yield
0.00%
Employees
326.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.16
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PSNL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$70.1M
Volume5.8M
P/E Ratio-4.38
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025Related Securities
Pricing info last updated June 27, 2025 (after market close)Other info last updated April 2, 2025